nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—ALB—multiple sclerosis	0.41	1	CbGaD
Sulfamethoxazole—ALB—Prednisone—multiple sclerosis	0.0558	0.179	CbGbCtD
Sulfamethoxazole—CYP3A4—Fingolimod—multiple sclerosis	0.0448	0.144	CbGbCtD
Sulfamethoxazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0288	0.0926	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—multiple sclerosis	0.028	0.0898	CbGbCtD
Sulfamethoxazole—CYP2C8—Dexamethasone—multiple sclerosis	0.0269	0.0863	CbGbCtD
Sulfamethoxazole—CYP3A4—Triamcinolone—multiple sclerosis	0.0219	0.0702	CbGbCtD
Sulfamethoxazole—NAT2—pineal body—multiple sclerosis	0.0216	0.374	CbGeAlD
Sulfamethoxazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.021	0.0675	CbGbCtD
Sulfamethoxazole—NAT1—pineal body—multiple sclerosis	0.0196	0.34	CbGeAlD
Sulfamethoxazole—CYP2C9—Dexamethasone—multiple sclerosis	0.0188	0.0602	CbGbCtD
Sulfamethoxazole—CYP3A4—Betamethasone—multiple sclerosis	0.0188	0.0602	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisolone—multiple sclerosis	0.0185	0.0594	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisone—multiple sclerosis	0.0175	0.0561	CbGbCtD
Sulfamethoxazole—CYP3A4—Dexamethasone—multiple sclerosis	0.0109	0.035	CbGbCtD
Sulfamethoxazole—NAT1—retina—multiple sclerosis	0.0059	0.102	CbGeAlD
Sulfamethoxazole—NAT1—medulla oblongata—multiple sclerosis	0.00427	0.0739	CbGeAlD
Sulfamethoxazole—NAT1—brain—multiple sclerosis	0.00245	0.0424	CbGeAlD
Sulfamethoxazole—NAT1—Biological oxidations—CYP27B1—multiple sclerosis	0.00202	0.0621	CbGpPWpGaD
Sulfamethoxazole—NAT1—Biological oxidations—CYP24A1—multiple sclerosis	0.00202	0.0621	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Irinotecan Pathway—BCHE—multiple sclerosis	0.000943	0.029	CbGpPWpGaD
Sulfamethoxazole—NAT2—Biological oxidations—CYP24A1—multiple sclerosis	0.000837	0.0258	CbGpPWpGaD
Sulfamethoxazole—NAT2—Biological oxidations—CYP27B1—multiple sclerosis	0.000837	0.0258	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000826	0.0254	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000826	0.0254	CbGpPWpGaD
Sulfamethoxazole—ALB—brain—multiple sclerosis	0.000671	0.0116	CbGeAlD
Sulfamethoxazole—PTGS1—spinal cord—multiple sclerosis	0.000594	0.0103	CbGeAlD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.00058	0.0179	CbGpPWpGaD
Sulfamethoxazole—Sulfamethazine—ALB—multiple sclerosis	0.000524	0.366	CrCbGaD
Sulfamethoxazole—Sulfamerazine—ALB—multiple sclerosis	0.000512	0.357	CrCbGaD
Sulfamethoxazole—PTGS1—nervous system—multiple sclerosis	0.0005	0.00867	CbGeAlD
Sulfamethoxazole—NAT1—Metabolism—SRM—multiple sclerosis	0.000489	0.0151	CbGpPWpGaD
Sulfamethoxazole—PTGS1—central nervous system—multiple sclerosis	0.000482	0.00834	CbGeAlD
Sulfamethoxazole—CYP2C8—brain—multiple sclerosis	0.000472	0.00817	CbGeAlD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000457	0.0141	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000457	0.0141	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.000457	0.0141	CbGpPWpGaD
Sulfamethoxazole—NAT1—Biological oxidations—POMC—multiple sclerosis	0.000454	0.014	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000447	0.0138	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000447	0.0138	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—nervous system—multiple sclerosis	0.000418	0.00724	CbGeAlD
Sulfamethoxazole—CYP3A4—central nervous system—multiple sclerosis	0.000402	0.00697	CbGeAlD
Sulfamethoxazole—Sulfamethizole—ALB—multiple sclerosis	0.000397	0.277	CrCbGaD
Sulfamethoxazole—PTGS1—brain—multiple sclerosis	0.000382	0.00662	CbGeAlD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000364	0.0112	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000356	0.011	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000356	0.011	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000352	0.0108	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000352	0.0108	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CYP27B1—multiple sclerosis	0.000345	0.0106	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CYP24A1—multiple sclerosis	0.000345	0.0106	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Cladribine—multiple sclerosis	0.000338	0.00181	CcSEcCtD
Sulfamethoxazole—Rash—Cladribine—multiple sclerosis	0.000335	0.00179	CcSEcCtD
Sulfamethoxazole—Hallucination—Dexamethasone—multiple sclerosis	0.000335	0.00179	CcSEcCtD
Sulfamethoxazole—Hallucination—Betamethasone—multiple sclerosis	0.000335	0.00179	CcSEcCtD
Sulfamethoxazole—Dermatitis—Cladribine—multiple sclerosis	0.000335	0.00179	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000335	0.00179	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000334	0.00179	CcSEcCtD
Sulfamethoxazole—Anorexia—Mitoxantrone—multiple sclerosis	0.000333	0.00178	CcSEcCtD
Sulfamethoxazole—Ataxia—Methotrexate—multiple sclerosis	0.000333	0.00178	CcSEcCtD
Sulfamethoxazole—Headache—Cladribine—multiple sclerosis	0.000333	0.00178	CcSEcCtD
Sulfamethoxazole—Depression—Prednisone—multiple sclerosis	0.000326	0.00174	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methylprednisolone—multiple sclerosis	0.000325	0.00174	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methylprednisolone—multiple sclerosis	0.000323	0.00172	CcSEcCtD
Sulfamethoxazole—Angioedema—Prednisolone—multiple sclerosis	0.000321	0.00172	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00032	0.00171	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000319	0.00171	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Azathioprine—multiple sclerosis	0.000319	0.0017	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000319	0.0017	CcSEcCtD
Sulfamethoxazole—Nausea—Cladribine—multiple sclerosis	0.000316	0.00169	CcSEcCtD
Sulfamethoxazole—Vertigo—Prednisolone—multiple sclerosis	0.000316	0.00169	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—GPC5—multiple sclerosis	0.000315	0.00971	CbGpPWpGaD
Sulfamethoxazole—Eye disorder—Dexamethasone—multiple sclerosis	0.000315	0.00168	CcSEcCtD
Sulfamethoxazole—Eye disorder—Betamethasone—multiple sclerosis	0.000315	0.00168	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000312	0.00167	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000308	0.00165	CcSEcCtD
Sulfamethoxazole—Convulsion—Prednisolone—multiple sclerosis	0.000305	0.00163	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000304	0.00163	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Methotrexate—multiple sclerosis	0.000303	0.00162	CcSEcCtD
Sulfamethoxazole—Fatigue—Mitoxantrone—multiple sclerosis	0.000301	0.00161	CcSEcCtD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000301	0.00927	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000301	0.00927	CbGpPWpGaD
Sulfamethoxazole—Pancreatitis—Methotrexate—multiple sclerosis	0.0003	0.00161	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Azathioprine—multiple sclerosis	0.000296	0.00158	CcSEcCtD
Sulfamethoxazole—Angioedema—Triamcinolone—multiple sclerosis	0.000295	0.00158	CcSEcCtD
Sulfamethoxazole—Angioedema—Methylprednisolone—multiple sclerosis	0.000295	0.00158	CcSEcCtD
Sulfamethoxazole—Hallucination—Prednisone—multiple sclerosis	0.000292	0.00156	CcSEcCtD
Sulfamethoxazole—UGT1A9—Biological oxidations—CYP27B1—multiple sclerosis	0.000291	0.00897	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—CYP24A1—multiple sclerosis	0.000291	0.00897	CbGpPWpGaD
Sulfamethoxazole—Pancytopenia—Methotrexate—multiple sclerosis	0.000291	0.00156	CcSEcCtD
Sulfamethoxazole—Vertigo—Triamcinolone—multiple sclerosis	0.00029	0.00155	CcSEcCtD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00029	0.00893	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00029	0.00893	CbGpPWpGaD
Sulfamethoxazole—Vertigo—Methylprednisolone—multiple sclerosis	0.00029	0.00155	CcSEcCtD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000289	0.00889	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000289	0.00889	CbGpPWpGaD
Sulfamethoxazole—Connective tissue disorder—Prednisone—multiple sclerosis	0.000288	0.00154	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000287	0.00885	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000287	0.00885	CbGpPWpGaD
Sulfamethoxazole—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000287	0.00153	CcSEcCtD
Sulfamethoxazole—Neutropenia—Methotrexate—multiple sclerosis	0.000286	0.00153	CcSEcCtD
Sulfamethoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000286	0.00881	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000286	0.00881	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Azathioprine—multiple sclerosis	0.000286	0.00153	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000286	0.00153	CcSEcCtD
Sulfamethoxazole—Cough—Triamcinolone—multiple sclerosis	0.000282	0.00151	CcSEcCtD
Sulfamethoxazole—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	0.000281	0.00866	CbGpPWpGaD
Sulfamethoxazole—Convulsion—Triamcinolone—multiple sclerosis	0.00028	0.0015	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00028	0.0015	CcSEcCtD
Sulfamethoxazole—Convulsion—Methylprednisolone—multiple sclerosis	0.000279	0.00149	CcSEcCtD
Sulfamethoxazole—Urticaria—Mitoxantrone—multiple sclerosis	0.000278	0.00149	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000276	0.00148	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000276	0.00148	CcSEcCtD
Sulfamethoxazole—Myalgia—Triamcinolone—multiple sclerosis	0.000275	0.00147	CcSEcCtD
Sulfamethoxazole—Vomiting—Azathioprine—multiple sclerosis	0.000275	0.00147	CcSEcCtD
Sulfamethoxazole—Pneumonia—Methotrexate—multiple sclerosis	0.000275	0.00147	CcSEcCtD
Sulfamethoxazole—Myalgia—Methylprednisolone—multiple sclerosis	0.000275	0.00147	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methylprednisolone—multiple sclerosis	0.000275	0.00147	CcSEcCtD
Sulfamethoxazole—Eye disorder—Prednisone—multiple sclerosis	0.000274	0.00147	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methotrexate—multiple sclerosis	0.000273	0.00146	CcSEcCtD
Sulfamethoxazole—Infestation—Methotrexate—multiple sclerosis	0.000273	0.00146	CcSEcCtD
Sulfamethoxazole—Rash—Azathioprine—multiple sclerosis	0.000273	0.00146	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000273	0.00146	CcSEcCtD
Sulfamethoxazole—Dermatitis—Azathioprine—multiple sclerosis	0.000272	0.00146	CcSEcCtD
Sulfamethoxazole—Depression—Methotrexate—multiple sclerosis	0.000272	0.00146	CcSEcCtD
Sulfamethoxazole—Headache—Azathioprine—multiple sclerosis	0.000271	0.00145	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000271	0.00145	CcSEcCtD
Sulfamethoxazole—Renal failure—Methotrexate—multiple sclerosis	0.000269	0.00144	CcSEcCtD
Sulfamethoxazole—Angioedema—Betamethasone—multiple sclerosis	0.000268	0.00143	CcSEcCtD
Sulfamethoxazole—Angioedema—Dexamethasone—multiple sclerosis	0.000268	0.00143	CcSEcCtD
Sulfamethoxazole—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000267	0.00821	CbGpPWpGaD
Sulfamethoxazole—Stomatitis—Methotrexate—multiple sclerosis	0.000266	0.00142	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Prednisone—multiple sclerosis	0.000265	0.00142	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000264	0.00141	CcSEcCtD
Sulfamethoxazole—Vertigo—Betamethasone—multiple sclerosis	0.000264	0.00141	CcSEcCtD
Sulfamethoxazole—Vertigo—Dexamethasone—multiple sclerosis	0.000264	0.00141	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000263	0.00141	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—RRM1—multiple sclerosis	0.000261	0.00805	CbGpPWpGaD
Sulfamethoxazole—Insomnia—Prednisolone—multiple sclerosis	0.000259	0.00139	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000258	0.00138	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000258	0.00138	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000258	0.00138	CcSEcCtD
Sulfamethoxazole—Mental disorder—Prednisone—multiple sclerosis	0.000257	0.00137	CcSEcCtD
Sulfamethoxazole—Nausea—Azathioprine—multiple sclerosis	0.000257	0.00137	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methylprednisolone—multiple sclerosis	0.000256	0.00137	CcSEcCtD
Sulfamethoxazole—Malnutrition—Prednisone—multiple sclerosis	0.000255	0.00137	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Methotrexate—multiple sclerosis	0.000255	0.00136	CcSEcCtD
Sulfamethoxazole—Convulsion—Betamethasone—multiple sclerosis	0.000254	0.00136	CcSEcCtD
Sulfamethoxazole—Convulsion—Dexamethasone—multiple sclerosis	0.000254	0.00136	CcSEcCtD
Sulfamethoxazole—Asthenia—Mitoxantrone—multiple sclerosis	0.000251	0.00134	CcSEcCtD
Sulfamethoxazole—Myalgia—Betamethasone—multiple sclerosis	0.00025	0.00134	CcSEcCtD
Sulfamethoxazole—Myalgia—Dexamethasone—multiple sclerosis	0.00025	0.00134	CcSEcCtD
Sulfamethoxazole—Hepatitis—Methotrexate—multiple sclerosis	0.000245	0.00131	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000242	0.00129	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—multiple sclerosis	0.00024	0.00129	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00024	0.00129	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00024	0.00128	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000239	0.00128	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000239	0.00128	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000239	0.00128	CcSEcCtD
Sulfamethoxazole—Insomnia—Triamcinolone—multiple sclerosis	0.000239	0.00128	CcSEcCtD
Sulfamethoxazole—Insomnia—Methylprednisolone—multiple sclerosis	0.000238	0.00127	CcSEcCtD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	0.000238	0.00731	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	0.000238	0.00731	CbGpPWpGaD
Sulfamethoxazole—Dyspnoea—Triamcinolone—multiple sclerosis	0.000235	0.00126	CcSEcCtD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000235	0.00724	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000235	0.00724	CbGpPWpGaD
Sulfamethoxazole—Nervous system disorder—Betamethasone—multiple sclerosis	0.000235	0.00126	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000235	0.00126	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000234	0.00125	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000234	0.00125	CcSEcCtD
Sulfamethoxazole—Angioedema—Prednisone—multiple sclerosis	0.000233	0.00125	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Triamcinolone—multiple sclerosis	0.000232	0.00124	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—multiple sclerosis	0.000232	0.00124	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000232	0.00124	CcSEcCtD
Sulfamethoxazole—Vertigo—Prednisone—multiple sclerosis	0.000229	0.00123	CcSEcCtD
Sulfamethoxazole—ALB—Platelet degranulation—PLEK—multiple sclerosis	0.000229	0.00706	CbGpPWpGaD
Sulfamethoxazole—Eye disorder—Methotrexate—multiple sclerosis	0.000229	0.00123	CcSEcCtD
Sulfamethoxazole—Tinnitus—Methotrexate—multiple sclerosis	0.000229	0.00122	CcSEcCtD
Sulfamethoxazole—Anorexia—Dexamethasone—multiple sclerosis	0.000228	0.00122	CcSEcCtD
Sulfamethoxazole—Anorexia—Betamethasone—multiple sclerosis	0.000228	0.00122	CcSEcCtD
Sulfamethoxazole—Urticaria—Prednisolone—multiple sclerosis	0.000228	0.00122	CcSEcCtD
Sulfamethoxazole—Fatigue—Triamcinolone—multiple sclerosis	0.000227	0.00122	CcSEcCtD
Sulfamethoxazole—Fatigue—Methylprednisolone—multiple sclerosis	0.000227	0.00121	CcSEcCtD
Sulfamethoxazole—Vomiting—Mitoxantrone—multiple sclerosis	0.000222	0.00119	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—multiple sclerosis	0.000221	0.00118	CcSEcCtD
Sulfamethoxazole—Convulsion—Prednisone—multiple sclerosis	0.000221	0.00118	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000221	0.00118	CcSEcCtD
Sulfamethoxazole—Rash—Mitoxantrone—multiple sclerosis	0.00022	0.00118	CcSEcCtD
Sulfamethoxazole—Dermatitis—Mitoxantrone—multiple sclerosis	0.00022	0.00118	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—multiple sclerosis	0.00022	0.00118	CcSEcCtD
Sulfamethoxazole—Headache—Mitoxantrone—multiple sclerosis	0.000219	0.00117	CcSEcCtD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000219	0.00673	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000218	0.00117	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000218	0.00117	CcSEcCtD
Sulfamethoxazole—Arthralgia—Prednisone—multiple sclerosis	0.000217	0.00116	CcSEcCtD
Sulfamethoxazole—Myalgia—Prednisone—multiple sclerosis	0.000217	0.00116	CcSEcCtD
Sulfamethoxazole—Insomnia—Betamethasone—multiple sclerosis	0.000216	0.00116	CcSEcCtD
Sulfamethoxazole—Insomnia—Dexamethasone—multiple sclerosis	0.000216	0.00116	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000216	0.00115	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000215	0.00115	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—multiple sclerosis	0.000215	0.00115	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methotrexate—multiple sclerosis	0.000213	0.00114	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Prednisolone—multiple sclerosis	0.000211	0.00113	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Betamethasone—multiple sclerosis	0.000211	0.00113	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Dexamethasone—multiple sclerosis	0.000211	0.00113	CcSEcCtD
Sulfamethoxazole—Urticaria—Triamcinolone—multiple sclerosis	0.00021	0.00112	CcSEcCtD
Sulfamethoxazole—Urticaria—Methylprednisolone—multiple sclerosis	0.000209	0.00112	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Triamcinolone—multiple sclerosis	0.000209	0.00112	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Prednisone—multiple sclerosis	0.000208	0.00111	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000208	0.00111	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Betamethasone—multiple sclerosis	0.000208	0.00111	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dexamethasone—multiple sclerosis	0.000208	0.00111	CcSEcCtD
Sulfamethoxazole—Nausea—Mitoxantrone—multiple sclerosis	0.000208	0.00111	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000207	0.0011	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000207	0.0011	CcSEcCtD
Sulfamethoxazole—Fatigue—Dexamethasone—multiple sclerosis	0.000206	0.0011	CcSEcCtD
Sulfamethoxazole—Fatigue—Betamethasone—multiple sclerosis	0.000206	0.0011	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Prednisone—multiple sclerosis	0.000204	0.00109	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—SRM—multiple sclerosis	0.000203	0.00626	CbGpPWpGaD
Sulfamethoxazole—Skin disorder—Prednisone—multiple sclerosis	0.000202	0.00108	CcSEcCtD
Sulfamethoxazole—Anorexia—Prednisone—multiple sclerosis	0.000199	0.00106	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000196	0.00105	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000196	0.00105	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000194	0.00104	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000194	0.00104	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—multiple sclerosis	0.000192	0.00103	CcSEcCtD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000191	0.00589	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000191	0.00589	CbGpPWpGaD
Sulfamethoxazole—Leukopenia—Methotrexate—multiple sclerosis	0.000191	0.00102	CcSEcCtD
Sulfamethoxazole—Urticaria—Dexamethasone—multiple sclerosis	0.00019	0.00102	CcSEcCtD
Sulfamethoxazole—Urticaria—Betamethasone—multiple sclerosis	0.00019	0.00102	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00019	0.00102	CcSEcCtD
Sulfamethoxazole—Dizziness—Prednisolone—multiple sclerosis	0.00019	0.00101	CcSEcCtD
Sulfamethoxazole—Asthenia—Triamcinolone—multiple sclerosis	0.000189	0.00101	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Betamethasone—multiple sclerosis	0.000189	0.00101	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dexamethasone—multiple sclerosis	0.000189	0.00101	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Betamethasone—multiple sclerosis	0.000189	0.00101	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dexamethasone—multiple sclerosis	0.000189	0.00101	CcSEcCtD
Sulfamethoxazole—Asthenia—Methylprednisolone—multiple sclerosis	0.000189	0.00101	CcSEcCtD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000189	0.00581	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000189	0.00581	CbGpPWpGaD
Sulfamethoxazole—Insomnia—Prednisone—multiple sclerosis	0.000189	0.00101	CcSEcCtD
Sulfamethoxazole—NAT2—Biological oxidations—POMC—multiple sclerosis	0.000188	0.0058	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Triamcinolone—multiple sclerosis	0.000187	0.000998	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—multiple sclerosis	0.000186	0.000996	CcSEcCtD
Sulfamethoxazole—Pruritus—Methylprednisolone—multiple sclerosis	0.000186	0.000996	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—multiple sclerosis	0.000185	0.000989	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Prednisone—multiple sclerosis	0.000183	0.000981	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—multiple sclerosis	0.000182	0.000972	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—multiple sclerosis	0.000182	0.000972	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Prednisone—multiple sclerosis	0.000181	0.000969	CcSEcCtD
Sulfamethoxazole—Rash—Prednisolone—multiple sclerosis	0.000181	0.000967	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisolone—multiple sclerosis	0.000181	0.000966	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00018	0.000965	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00018	0.000963	CcSEcCtD
Sulfamethoxazole—Fatigue—Prednisone—multiple sclerosis	0.00018	0.000961	CcSEcCtD
Sulfamethoxazole—Headache—Prednisolone—multiple sclerosis	0.00018	0.000961	CcSEcCtD
Sulfamethoxazole—Dizziness—Triamcinolone—multiple sclerosis	0.000174	0.000933	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000174	0.000932	CcSEcCtD
Sulfamethoxazole—Dizziness—Methylprednisolone—multiple sclerosis	0.000174	0.000931	CcSEcCtD
Sulfamethoxazole—UGT1A9—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000172	0.00529	CbGpPWpGaD
Sulfamethoxazole—Asthenia—Dexamethasone—multiple sclerosis	0.000172	0.000918	CcSEcCtD
Sulfamethoxazole—Asthenia—Betamethasone—multiple sclerosis	0.000172	0.000918	CcSEcCtD
Sulfamethoxazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000172	0.00528	CbGpPWpGaD
Sulfamethoxazole—Nervous system disorder—Methotrexate—multiple sclerosis	0.000171	0.000914	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000171	0.000912	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00017	0.000911	CcSEcCtD
Sulfamethoxazole—Nausea—Prednisolone—multiple sclerosis	0.00017	0.000911	CcSEcCtD
Sulfamethoxazole—Pruritus—Dexamethasone—multiple sclerosis	0.000169	0.000906	CcSEcCtD
Sulfamethoxazole—Pruritus—Betamethasone—multiple sclerosis	0.000169	0.000906	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methotrexate—multiple sclerosis	0.000169	0.000905	CcSEcCtD
Sulfamethoxazole—Vomiting—Triamcinolone—multiple sclerosis	0.000168	0.000897	CcSEcCtD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000168	0.00516	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Methylprednisolone—multiple sclerosis	0.000167	0.000895	CcSEcCtD
Sulfamethoxazole—Rash—Triamcinolone—multiple sclerosis	0.000166	0.000889	CcSEcCtD
Sulfamethoxazole—Dermatitis—Triamcinolone—multiple sclerosis	0.000166	0.000889	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—multiple sclerosis	0.000166	0.000888	CcSEcCtD
Sulfamethoxazole—Rash—Methylprednisolone—multiple sclerosis	0.000166	0.000887	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methylprednisolone—multiple sclerosis	0.000166	0.000887	CcSEcCtD
Sulfamethoxazole—Urticaria—Prednisone—multiple sclerosis	0.000166	0.000885	CcSEcCtD
Sulfamethoxazole—Headache—Triamcinolone—multiple sclerosis	0.000165	0.000884	CcSEcCtD
Sulfamethoxazole—Headache—Methylprednisolone—multiple sclerosis	0.000165	0.000882	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Prednisone—multiple sclerosis	0.000165	0.000881	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Prednisone—multiple sclerosis	0.000165	0.000881	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dexamethasone—multiple sclerosis	0.000164	0.000876	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Betamethasone—multiple sclerosis	0.000164	0.000876	CcSEcCtD
Sulfamethoxazole—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	0.000162	0.00497	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000159	0.000849	CcSEcCtD
Sulfamethoxazole—Dizziness—Betamethasone—multiple sclerosis	0.000158	0.000846	CcSEcCtD
Sulfamethoxazole—Dizziness—Dexamethasone—multiple sclerosis	0.000158	0.000846	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—multiple sclerosis	0.000158	0.000843	CcSEcCtD
Sulfamethoxazole—Nausea—Triamcinolone—multiple sclerosis	0.000157	0.000838	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000157	0.00482	CbGpPWpGaD
Sulfamethoxazole—Nausea—Methylprednisolone—multiple sclerosis	0.000156	0.000836	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—multiple sclerosis	0.000155	0.00083	CcSEcCtD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000155	0.00477	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000155	0.00477	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Prednisone—multiple sclerosis	0.000154	0.000821	CcSEcCtD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000153	0.00472	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000153	0.00472	CbGpPWpGaD
Sulfamethoxazole—Dyspepsia—Methotrexate—multiple sclerosis	0.000153	0.00082	CcSEcCtD
Sulfamethoxazole—Vomiting—Dexamethasone—multiple sclerosis	0.000152	0.000814	CcSEcCtD
Sulfamethoxazole—Vomiting—Betamethasone—multiple sclerosis	0.000152	0.000814	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—multiple sclerosis	0.000151	0.00081	CcSEcCtD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000151	0.00466	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000151	0.00466	CbGpPWpGaD
Sulfamethoxazole—Rash—Betamethasone—multiple sclerosis	0.000151	0.000807	CcSEcCtD
Sulfamethoxazole—Rash—Dexamethasone—multiple sclerosis	0.000151	0.000807	CcSEcCtD
Sulfamethoxazole—Dermatitis—Dexamethasone—multiple sclerosis	0.000151	0.000806	CcSEcCtD
Sulfamethoxazole—Dermatitis—Betamethasone—multiple sclerosis	0.000151	0.000806	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00015	0.000804	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—multiple sclerosis	0.00015	0.000803	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—BCHE—multiple sclerosis	0.00015	0.00462	CbGpPWpGaD
Sulfamethoxazole—Headache—Betamethasone—multiple sclerosis	0.00015	0.000802	CcSEcCtD
Sulfamethoxazole—Headache—Dexamethasone—multiple sclerosis	0.00015	0.000802	CcSEcCtD
Sulfamethoxazole—Asthenia—Prednisone—multiple sclerosis	0.00015	0.0008	CcSEcCtD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000149	0.0046	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Prednisone—multiple sclerosis	0.000147	0.000789	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—CYP24A1—multiple sclerosis	0.000143	0.00441	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP27B1—multiple sclerosis	0.000143	0.00441	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Prednisone—multiple sclerosis	0.000143	0.000763	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000142	0.000762	CcSEcCtD
Sulfamethoxazole—Nausea—Dexamethasone—multiple sclerosis	0.000142	0.00076	CcSEcCtD
Sulfamethoxazole—Nausea—Betamethasone—multiple sclerosis	0.000142	0.00076	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.00014	0.0043	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000139	0.00429	CbGpPWpGaD
Sulfamethoxazole—Urticaria—Methotrexate—multiple sclerosis	0.000138	0.00074	CcSEcCtD
Sulfamethoxazole—Dizziness—Prednisone—multiple sclerosis	0.000138	0.000737	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—multiple sclerosis	0.000138	0.000736	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methotrexate—multiple sclerosis	0.000138	0.000736	CcSEcCtD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000135	0.00417	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Prednisone—multiple sclerosis	0.000133	0.000709	CcSEcCtD
Sulfamethoxazole—Rash—Prednisone—multiple sclerosis	0.000131	0.000703	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisone—multiple sclerosis	0.000131	0.000702	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—GPC5—multiple sclerosis	0.000131	0.00403	CbGpPWpGaD
Sulfamethoxazole—Headache—Prednisone—multiple sclerosis	0.000131	0.000698	CcSEcCtD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.000129	0.00397	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Methotrexate—multiple sclerosis	0.000128	0.000686	CcSEcCtD
Sulfamethoxazole—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	0.000126	0.00387	CbGpPWpGaD
Sulfamethoxazole—Asthenia—Methotrexate—multiple sclerosis	0.000125	0.000668	CcSEcCtD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000125	0.00384	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000125	0.00384	CbGpPWpGaD
Sulfamethoxazole—Nausea—Prednisone—multiple sclerosis	0.000124	0.000662	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—multiple sclerosis	0.000123	0.000659	CcSEcCtD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000123	0.00379	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000123	0.00379	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Methotrexate—multiple sclerosis	0.000119	0.000637	CcSEcCtD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000118	0.00363	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Methotrexate—multiple sclerosis	0.000115	0.000616	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000112	0.00344	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000112	0.00344	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Methotrexate—multiple sclerosis	0.000111	0.000592	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—multiple sclerosis	0.00011	0.000587	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—multiple sclerosis	0.00011	0.000587	CcSEcCtD
Sulfamethoxazole—Headache—Methotrexate—multiple sclerosis	0.000109	0.000584	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000109	0.00334	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—RRM1—multiple sclerosis	0.000109	0.00334	CbGpPWpGaD
Sulfamethoxazole—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	0.000107	0.0033	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.000106	0.00325	CbGpPWpGaD
Sulfamethoxazole—Nausea—Methotrexate—multiple sclerosis	0.000103	0.000553	CcSEcCtD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000102	0.00313	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL4—multiple sclerosis	0.000102	0.00313	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000101	0.00312	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000101	0.0031	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	9.99e-05	0.00307	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	9.92e-05	0.00306	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	9.86e-05	0.00303	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.12e-05	0.00281	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.12e-05	0.00281	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—APOE—multiple sclerosis	9.03e-05	0.00278	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	8.94e-05	0.00275	CbGpPWpGaD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.94e-05	0.00275	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	8.88e-05	0.00273	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SELPLG—multiple sclerosis	8.49e-05	0.00261	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MERTK—multiple sclerosis	8.49e-05	0.00261	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CD58—multiple sclerosis	8.49e-05	0.00261	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	8.33e-05	0.00256	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	8.24e-05	0.00254	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	8.24e-05	0.00254	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.12e-05	0.0025	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.12e-05	0.0025	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—ICAM1—multiple sclerosis	8.07e-05	0.00249	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.01e-05	0.00247	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—POMC—multiple sclerosis	7.76e-05	0.00239	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	7.6e-05	0.00234	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	7.55e-05	0.00232	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—CCL2—multiple sclerosis	7.22e-05	0.00222	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SRM—multiple sclerosis	7.07e-05	0.00218	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—ALB—multiple sclerosis	7.07e-05	0.00218	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	6.78e-05	0.00209	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	6.73e-05	0.00207	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—POMC—multiple sclerosis	6.55e-05	0.00202	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.52e-05	0.00201	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.5e-05	0.002	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	6.41e-05	0.00197	CbGpPWpGaD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.24e-05	0.00192	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—BCHE—multiple sclerosis	6.23e-05	0.00192	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IFNG—multiple sclerosis	6.14e-05	0.00189	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.99e-05	0.00184	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.89e-05	0.00181	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.89e-05	0.00181	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.86e-05	0.0018	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.86e-05	0.0018	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SRM—multiple sclerosis	5.77e-05	0.00178	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	5.74e-05	0.00177	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL1B—multiple sclerosis	5.48e-05	0.00169	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL2—multiple sclerosis	5.46e-05	0.00168	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—POMC—multiple sclerosis	5.34e-05	0.00165	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.29e-05	0.00163	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PLEK—multiple sclerosis	5.25e-05	0.00162	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP27B1—multiple sclerosis	4.98e-05	0.00153	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP24A1—multiple sclerosis	4.98e-05	0.00153	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	4.92e-05	0.00151	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	4.89e-05	0.0015	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	4.88e-05	0.0015	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.87e-05	0.0015	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.79e-05	0.00148	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.79e-05	0.00148	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GPC5—multiple sclerosis	4.56e-05	0.0014	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.54e-05	0.0014	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.35e-05	0.00134	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—TGFB1—multiple sclerosis	4.31e-05	0.00133	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.3e-05	0.00132	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP27B1—multiple sclerosis	4.06e-05	0.00125	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP24A1—multiple sclerosis	4.06e-05	0.00125	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TNF—multiple sclerosis	3.98e-05	0.00122	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.97e-05	0.00122	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	3.97e-05	0.00122	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	3.94e-05	0.00121	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—RRM1—multiple sclerosis	3.78e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—APOE—multiple sclerosis	3.75e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SRM—multiple sclerosis	3.72e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GPC5—multiple sclerosis	3.72e-05	0.00114	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SRM—multiple sclerosis	3.7e-05	0.00114	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SELE—multiple sclerosis	3.7e-05	0.00114	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—TGFB1—multiple sclerosis	3.65e-05	0.00112	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.59e-05	0.00111	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	3.54e-05	0.00109	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.49e-05	0.00107	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	3.48e-05	0.00107	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—POMC—multiple sclerosis	3.45e-05	0.00106	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—POMC—multiple sclerosis	3.22e-05	0.000992	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL6—multiple sclerosis	3.21e-05	0.000988	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.17e-05	0.000977	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	3.16e-05	0.000973	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—RRM1—multiple sclerosis	3.08e-05	0.000948	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SRM—multiple sclerosis	3.03e-05	0.000933	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ALB—multiple sclerosis	2.94e-05	0.000904	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.93e-05	0.000902	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.81e-05	0.000865	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—ITGA4—multiple sclerosis	2.67e-05	0.000823	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IFNB1—multiple sclerosis	2.65e-05	0.000817	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.62e-05	0.000808	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.62e-05	0.000808	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP24A1—multiple sclerosis	2.61e-05	0.000803	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP27B1—multiple sclerosis	2.61e-05	0.000803	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.56e-05	0.00079	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.55e-05	0.000785	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	2.55e-05	0.000785	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.52e-05	0.000775	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.4e-05	0.000739	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.39e-05	0.000735	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPC5—multiple sclerosis	2.39e-05	0.000735	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.29e-05	0.000707	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—BCHE—multiple sclerosis	2.17e-05	0.000668	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.14e-05	0.000657	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.14e-05	0.000657	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.09e-05	0.000643	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	2.08e-05	0.000639	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.05e-05	0.000632	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SRM—multiple sclerosis	2e-05	0.000615	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.99e-05	0.000612	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—RRM1—multiple sclerosis	1.98e-05	0.000609	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.95e-05	0.000601	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.87e-05	0.000576	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.85e-05	0.00057	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2RA—multiple sclerosis	1.83e-05	0.000562	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—BCHE—multiple sclerosis	1.77e-05	0.000544	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.62e-05	0.000499	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.62e-05	0.000498	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.59e-05	0.000489	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.54e-05	0.000475	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.53e-05	0.000472	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.41e-05	0.000434	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.41e-05	0.000434	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.33e-05	0.000408	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.32e-05	0.000406	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOE—multiple sclerosis	1.3e-05	0.000402	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.29e-05	0.000397	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.26e-05	0.000387	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.21e-05	0.000372	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.000352	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.00035	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—POMC—multiple sclerosis	1.12e-05	0.000345	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.08e-05	0.000332	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—multiple sclerosis	1.07e-05	0.000329	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.07e-05	0.000329	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOE—multiple sclerosis	1.06e-05	0.000327	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—multiple sclerosis	1.02e-05	0.000315	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.83e-06	0.000303	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BCHE—multiple sclerosis	9.29e-06	0.000286	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—POMC—multiple sclerosis	9.14e-06	0.000281	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—multiple sclerosis	8.35e-06	0.000257	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—multiple sclerosis	8.33e-06	0.000256	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK1—multiple sclerosis	8.19e-06	0.000252	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOE—multiple sclerosis	6.87e-06	0.000212	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOE—multiple sclerosis	6.83e-06	0.00021	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.13e-06	0.000189	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—POMC—multiple sclerosis	5.9e-06	0.000182	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—POMC—multiple sclerosis	5.87e-06	0.000181	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOE—multiple sclerosis	5.59e-06	0.000172	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—multiple sclerosis	5.38e-06	0.000166	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—POMC—multiple sclerosis	4.8e-06	0.000148	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—multiple sclerosis	4.38e-06	0.000135	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOE—multiple sclerosis	3.69e-06	0.000114	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—POMC—multiple sclerosis	3.17e-06	9.75e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—multiple sclerosis	2.89e-06	8.89e-05	CbGpPWpGaD
